Overall When the Wake Forest (WF) Clinical and Translational Science Institute (CTSI) joined the CTSA consortium in August 2015, our goal was to use our resources to catalyze WF?s transformation into an exemplary Learning Health System in which ?science, informatics, incentives, and culture are aligned for continuous improvement and innovation, with best practices seamlessly embedded in the delivery process and new knowledge captured as an integral by-product of the delivery experience.? We seek to extend this framework by integrating traditional academic goals of T0 ? T4 discovery, translation, and scholarship to form a new vision?the Academic Learning Health System (aLHS). In our initial 3 years of funding, we have progressed towards our goal, establishing an integrated research governance model, with the CTSI at its core, to realize efficiencies and address roadblocks that hamper translational progress. We established Translational Catalysts to link the academic and clinical enterprises and designed training programs to develop the skills our workforce needs to make the aLHS a reality. We developed foundational informatics infrastructures essential to learning and growing, engaged communities and stakeholders to integrate diverse perspectives into the fabric of our aLHS, and created a milieu for nurturing innovative translational methods. We became a valued member of the CTSA national network, actively collaborating with 20 CTSA hubs, and shared our world-class nonhuman primate models with the consortium. With these successes, we turn to the next 5 years with strong assets in leadership, structure, scholarship, and culture that uniquely position us to realize the aLHS ideal. We will fully integrate our new Translational Catalysts ? biomedical informatics, implementation science, precision medicine, healthcare innovation, and clinical trials ? and use them, along with incentives for academic engagement, to mobilize our growing clinical network. We will develop, implement, and broadly disseminate improved methods and processes that will increase the efficiency, safety, and reproducibility of preclinical and clinical science. We will partner with our community to integrate special populations, and support health research across the lifespan. We will train our workforce for new roles, especially in team environments, with new training programs (e.g., TL1 aLHS Scholars Program, the Learning TREE online educational platform for individualized learning, Research-in-Action) and broaden our highly successful KL2 training for early-career faculty. We will serve as a hub for biomedical informatics, accelerating progress by enhancing existing resources, promoting collaboration and data sharing, and building new capacity. We will remain committed to inclusiveness, mutual respect, and multiple perspectives to act as a catalyst for change and healthy equity. We will further extend the reach of the aLHS into the communities served by our expanding health system and will broaden our collaborations with other CTSA hubs to share best practices and export the aLHS model ? all guided by our ultimate goal of improving the health of our region and nation. Page 243 Project Summary/Abstract Contact PD/PI: MCCLAIN, DONALD A. Narrative: Overall The Wake Forest Clinical and Translational Science Institute seeks to become the model of an integrated Academic Learning Health System in which we develop, implement, offer tailored training tools, and broadly disseminate improved methods and processes to increase the efficiency, safety, and reproducibility of preclinical and clinical science. We will build on our achievements to fully integrate our new Translational Catalysts ? biomedical informatics, implementation science, precision medicine, healthcare innovation and clinical trials ? and use them to develop and test initiatives, deploying research findings across our growing clinical network. We will remain committed to training the next generation of scientists and leaders and will partner with our community and CTSA hubs to integrate special populations and support research across the lifespan to extend the benefits of our progress to the widest possible audience. Page 244

Public Health Relevance

The Wake Forest Clinical and Translational Science Institute seeks to become the model of an integrated Academic Learning Health System in which we develop, implement, offer tailored training tools, and broadly disseminate improved methods and processes to increase the efficiency, safety, and reproducibility of preclinical and clinical science. We will build on our achievements to fully integrate our new Translational Catalysts ? biomedical informatics, implementation science, precision medicine, healthcare innovation and clinical trials ? and use them to develop and test initiatives, deploying research findings across our growing clinical network. We will remain committed to training the next generation of scientists and leaders and will partner with our community and CTSA hubs to integrate special populations and support research across the lifespan to extend the benefits of our progress to the widest possible audience.

Agency
National Institute of Health (NIH)
Institute
National Center for Advancing Translational Sciences (NCATS)
Type
Linked Specialized Center Cooperative Agreement (UL1)
Project #
3UL1TR001420-06S3
Application #
10171948
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Gopal-Srivastava, Rashmi
Project Start
2015-08-13
Project End
2024-06-30
Budget Start
2020-07-06
Budget End
2021-06-30
Support Year
6
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
McClain, Donald A; Sharma, Neeraj K; Jain, Shalini et al. (2018) Adipose Tissue Transferrin and Insulin Resistance. J Clin Endocrinol Metab 103:4197-4208
Irby, Megan Bennett; Hamlin, DeWanna; Rhoades, Lynn et al. (2018) Violence as a health disparity: Adolescents' perceptions of violence depicted through photovoice. J Community Psychol 46:1026-1044
Seeman, Teresa; Thomas, Duncan; Merkin, Sharon Stein et al. (2018) The Great Recession worsened blood pressure and blood glucose levels in American adults. Proc Natl Acad Sci U S A 115:3296-3301
Munger Clary, Heidi M; Snively, Beverly M; Hamberger, Marla J (2018) Anxiety is common and independently associated with clinical features of epilepsy. Epilepsy Behav 85:64-71
Kim, Ji Hyun; Seol, Young-Joon; Ko, In Kap et al. (2018) 3D Bioprinted Human Skeletal Muscle Constructs for Muscle Function Restoration. Sci Rep 8:12307
Aaron, Carrie P; Schwartz, Joseph E; Hoffman, Eric A et al. (2018) A Longitudinal Cohort Study of Aspirin Use and Progression of Emphysema-like Lung Characteristics on CT Imaging: The MESA Lung Study. Chest 154:41-50
Andrews, Joseph E; Moore, J Brian; Weinberg, Richard B et al. (2018) Ensuring respect for persons in COMPASS: a cluster randomised pragmatic clinical trial. J Med Ethics 44:560-566
Praharaj, Prakash P; Bhutia, Sujit K; Nagrath, Sunitha et al. (2018) Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine. Biochim Biophys Acta Rev Cancer 1869:117-127
Zhang, Yiyi; Guallar, Eliseo; Malhotra, Saurabh et al. (2018) Carotid Artery Wall Thickness and Incident Cardiovascular Events: A Comparison between US and MRI in the Multi-Ethnic Study of Atherosclerosis (MESA). Radiology 289:649-657
Ash, Samuel Y; Rahaghi, Farbod N; Come, Carolyn E et al. (2018) Pruning of the Pulmonary Vasculature in Asthma. The Severe Asthma Research Program (SARP) Cohort. Am J Respir Crit Care Med 198:39-50

Showing the most recent 10 out of 241 publications